VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA
| Autor: | Martin, L.K., Li, X., Kleiber, B., Ellison, E.C., Bloomston, M., Zalupski, M., Bekaii-Saab, T.S. * |
|---|---|
| Zdroj: | In Annals of Oncology November 2012 23(11):2812-2820 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|